3-[(19Z)-15,16-Dihydroxy-19-dotriaconten-1-yl]-5-methyl-2(5H)-furanone

Metabolite details

Identifier

HVFRQLAWDLEDRL-FLFQWRMESA-N

InChI Key

HVFRQLAWDLEDRL-FLFQWRMESA-N

IUPAC name

4-[(Z)-15,16-dihydroxydotriacont-19-enyl]-2-methyl-2H-uran-5-one

Preferred name

3-[(19Z)-15,16-Dihydroxy-19-dotriaconten-1-yl]-5-methyl-2(5H)-furanone

INN name

—

Synonym

—

ChEBI

CHEBI:176692

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

• Control_vs_AONFH_Stage_III_IV
• wild_type_vs_patA_deletion